Sustained release of cisplatin from multivesicular liposomes: Potentiation of antitumor efficacy against S180 murine carcinoma

Journal of Pharmaceutical Sciences

Volumn 93, Issue 7, 2004, Pages 1718-1724

  Xiao, Chaoju ^a   Qi, Xianrong ^a   Maitani, Yoshie ^b   Nagai, Tsuneji ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Cisplatin; Multivesicular liposomes; Pharmacokinetics; S180 tumor; Sustained release; Therapeutic efficacy

Indexed keywords

CISPLATIN; CISPLATIN MULTIVESICULAR LIPOSOME; LIPOSOME; MULTIVESICULAR LIPOSOME; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CIRCULATION TIME; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG LOADING; DRUG POTENTIATION; DRUG SPLEEN LEVEL; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; ENCAPSULATION; IN VITRO STUDY; INTERMETHOD COMPARISON; LOADING TEST; MOUSE; MOUSE STRAIN; NONHUMAN; PARTICLE SIZE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE PREPARATION; TISSUE DISTRIBUTION;

EID: 3042690466     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20086     Document Type: Article

References (20)

1. Durant JR. 1980. Cisplatin: A clinical overview. In: Prestayko AW, Crooke ST, Carter SK, editors. Cisplatin: Current status and new developments. New York: Academic Press, pp 317-321.
2. Garcia-Contreras L, Abu-Izza K, Lu DR. 1997. Biodegradable cisplatin microspheres for brain implantation: Preparation and characterization. Pharm Dev Technol 2(1):53-65.
3. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis PG, Karydas AG, Ithakissios DS. 2002. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 79:123-135.
4. Steerenberg PA, Storm G, de Groot G, Claessen A, Bergers JJ, Franken MA, van Hoesel QG, Wubs KL, de Jong WH. 1988. Liposomes as a drug carrier system for cis-diamminedichloroplatinum(II). II. Antitumor resistance in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother Pharmacol 21:299-307.
5. Mizumura Y, Matsumura Y, Hamaguchi T, Nishiyama N, Kataoka K, Kawaguchi T, Kawaguchi M, Hrushesky WJ, Moriyasu F, Kakizoe T. 2001. Cisplatin- incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res 92(3):328-336.
6. Newman MS, Colbern GT, Working PK, Engbers C, Amantea MA. 1999. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother Pharmacol 43:1-7.
7. Freise J, Mueller WH, Magerstedt P, Schmoll HJ. 1982. Pharmacokinetics of liposome encapsulated cisplatin in rats. Arch Int Pharmacodyn Ther 258:180-192.
8. Kim S, Turker MS, Chi EY, Sela S, Martin GM. 1983. Preparation of multivesicular liposomes. Biochim Biophys Acta 728:339-348.
9. Ye Q, Asherman J, Stevenson M, Brownson E, Katre NV. 2000. DepoFoam™ technology: A vehicle for controlled delivery of protein and peptide drugs. J Control Release 64:155-166.
10. Murry DJ, Blaney SM. 2000. Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother 34:1173-1178.
11. Li WJ. 1989. Determination of cisplatin in biological tissues and fluids by graphite furnace atomic absorption spectrometry. Chin J Pharm Anal 9:82-85.
12. Qi XR, Maitani Y, Nagai T. 1995. Effect of soybean-derived sterols on the in vitro stability and the blood circulation of liposomes in mice. Int J Pharm 114:33-41.
13. Qi XR, Maitani Y, Nagai T, Wei SL. 1997. Comparative pharmacokinetics and antitumor efficacy of doxorubicin encapsulated in soybean-derived sterols and poly(ethylene glycol) liposomes in mice. Int J Pharm 146:31-39.
14. Anonymous. 2000. First phase II results of cisplatin/epinephrine in primary liver cancer. Oncology 14(1):89.
15. Colbern GT, Hiller AJ, Musterer RS, Working PK, Henderson IC. 1999. Antitumor activity of Herceptin® in combination with STEALTH® liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model. J Inorg Biochem 77:117-120.
16. Bandak S, Goren D, Horowitz A, Tzemach D, Gabizon A. 1999. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs 10:911-920.
17. Kim T, Murdane S, Gruber A, Kim S. 1996. Sustained-release morphine for epidural analgesia in rats. Anesthesiology 85(2):331-338.
18. Katre NV, Asherman J, Schaefer H, Hora M. 1998. Multivesicular liposome (DepoFoam™) technology for the sustained delivery of insulin-like growth factor-I (IGF-I). J Pharm Sci 87(11):1341-1346.
19. Xi NZ. 1996. Pharmaceutical science, 3rd ed. Beijing: People's Health Press, p 455.
20. Tang CS, Su JY, Li ZP, Zhang LZ, Yang J, Qi M, Liu FA, Tang J. 1992. The feasibility study of treating myocardial ischemia disease by the liposome-directed drug delivery system. Science in China (Series B) 2:165-171.